Chronic dose-response curve of enalapril in essential hypertensives

American Journal of Hypertension

Volumn 2, Issue 5, 1989, Pages 352-354

  Salvetti, A ^a   Arzilli, F ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

Dose response curve; Enalapril; Essential hypertension

Indexed keywords

ENALAPRIL;

ADULT; AGED; ESSENTIAL HYPERTENSION; FEMALE; HEMODYNAMIC MONITORING; HUMAN; HYPOTENSION; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION;

ADULT; AGED; BLOOD PRESSURE; CLINICAL TRIALS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; ENALAPRIL; FEMALE; HUMAN; HYPERTENSION; ITALY; MALE; MIDDLE AGE; RANDOM ALLOCATION; TIME FACTORS;

EID: 0024551686     PISSN: 08957061     EISSN: 19417225     Source Type: Journal    
DOI: 10.1093/ajh/2.5.352     Document Type: Article

References (9)

1. Todd PA, Heel RC: Enalapril. A review of its pharmacodynamic and pharmacokinetic properties, and therapeuic use in hypertension and congestive heart failure. Drug 1986;31:198-248.
2. McFate Smith W: Long-term clinical experience with enalapril, in Doyle AE, Beam AG (eds): Hypertension and the Angiotensin System: Therapeutic Approaches. New York, Raven Press, 1983, p 261-279.
3. Arzilli F, Magagna A, Giovannetti et al R,: Acute dose- response curve of enalapril in renovascular hypertensives. Am J Hypertens 1988; 1:75s-78s.
4. Gomez HJ, Cirillo VJ, Jones KH: The clinical pharmacology of enalapril. J Hypertens 1983;1:65s-70s.
5. Salvetti A, Pedrinelli R, Arzilli et al F,: Angiotensin-converting enzyme inhibitors in hypertension: a review. Int J Pharmacol Res 1985;v(6):429-438.
6. Ferguson RK, Vlasses PH, Swanson et al BN,: Effects of enalapril, a new converting enzyme inhibitor, in hypertension. Clin Pharmacol Ther 1982;32:48-53.
7. Gavras H, Biollaz J, Waeben et al B,: Effects of the new oral angiotensin converting enzyme inhibitor MK-421 in human hypertension. Clin Exp Hypertens [A] 1982;A4:303-314.
8. Bergstrand R, Herlitz H, Johansson et al S,: Effective dose range of enalapril in mild to moderate essential hypertension. Br J Clin Pharmacol 1985;19:605-611.
9. Chrysant SG, Brown RD, Kem et al DCl: Antihypertensive and metabolic effects of a new converting enzyme inhibitor, enalapril. Clin Pharmacol Ther 1983;33:741-746.